A detailed history of California State Teachers Retirement System transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 3,049 shares of GLUE stock, worth $21,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,049
Previous 2,208 38.09%
Holding current value
$21,495
Previous $8,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.59 - $6.97 $3,019 - $5,861
841 Added 38.09%
3,049 $16,000
Q2 2024

Aug 14, 2024

SELL
$3.38 - $7.86 $3,052 - $7,097
-903 Reduced 29.03%
2,208 $8,000
Q1 2024

May 15, 2024

SELL
$4.26 - $8.46 $8,132 - $16,150
-1,909 Reduced 38.03%
3,111 $21,000
Q4 2023

Feb 13, 2024

SELL
$2.5 - $5.93 $97,035 - $230,167
-38,814 Reduced 88.55%
5,020 $28,000
Q3 2023

Nov 14, 2023

SELL
$4.78 - $7.22 $15,382 - $23,233
-3,218 Reduced 6.84%
43,834 $209,000
Q2 2023

Aug 21, 2023

BUY
$4.53 - $8.4 $86,210 - $159,860
19,031 Added 67.92%
47,052 $322,000
Q1 2023

May 09, 2023

SELL
$5.95 - $8.21 $386 - $533
-65 Reduced 0.23%
28,021 $218,000
Q4 2022

Feb 14, 2023

BUY
$6.71 - $9.72 $4,723 - $6,842
704 Added 2.57%
28,086 $213,000
Q3 2022

Nov 18, 2022

SELL
$7.17 - $12.16 $3,248 - $5,508
-453 Reduced 1.63%
27,382 $224,000
Q2 2022

Aug 15, 2022

BUY
$6.15 - $14.99 $33,357 - $81,305
5,424 Added 24.2%
27,835 $269,000
Q1 2022

May 16, 2022

BUY
$10.36 - $20.41 $60,170 - $118,541
5,808 Added 34.98%
22,411 $314,000
Q4 2021

Feb 15, 2022

BUY
$16.28 - $27.15 $168,514 - $281,029
10,351 Added 165.56%
16,603 $339,000
Q3 2021

Nov 15, 2021

BUY
$18.59 - $42.21 $116,224 - $263,896
6,252 New
6,252 $139,000

Others Institutions Holding GLUE

About Monte Rosa Therapeutics, Inc.


  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $329M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.